Clinical Trial Update: Molecular Markers in Thyroid Cancer

View source ↗

Summary

A completed clinical trial at OHSU Knight Cancer Institute focusing on molecular markers in thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Thyroid Cancer | Status: COMPLETED